Insys Therapeutic – Hot or Not

PUBLISHED: Thu, 07 Sep 2017 05:00:58 GMT

Insys Therapeutic (Nasdaq:INSY) is a commercial-stage specialty pharmaceutical company which mostly focuses on pain management products. It has a market cap of $673 million, and is not profitabl.. Guest Devin Shutte from The Robert Group and resident expert Paul Theron from Vestact decide whether Insys Therapeutic is hot or not.

Sign Up for Our Newsletter Daily Update
Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent.
Get this delivered to your inbox, and more info about about our products and services. By signing up for newsletters, you are agreeing to our Terms of Use and Privacy Policy.